Valuation : Ovation Science Inc.

Market Cap 1.15M 833K 718K 674K 616K 78.73M 1.16M 7.98M 3.09M 40.38M 3.13M 3.06M 130M P/E 2024
-2.68x
P/E 2025 -2.26x
Enterprise Value 1.36M 985K 849K 798K 729K 93.12M 1.37M 9.43M 3.65M 47.76M 3.7M 3.62M 154M EV / Sales 2024
13.2x
EV / Sales 2025 25.7x
Free-Float
76.56%
Yield 2024 *
-
Yield 2025 -
1 day-79.67%
1 month-79.67%
3 months-78.57%
6 months-64.62%
Current year-74.58%
Current year 0.01
Extreme 0.007
0.08
1 year 0.01
Extreme 0.007
0.08
3 years 0.01
Extreme 0.007
0.12
5 years 0
Extreme 0.0023
0.12
10 years 0
Extreme 0.0023
0.48
Manager TitleAgeSince
Director of Finance/CFO 63 2023-10-29
Chief Executive Officer 77 2017-10-03
Director TitleAgeSince
Director/Board Member 77 2017-10-03
Director/Board Member 63 2017-10-03
Director/Board Member 86 2018-02-01
Change 5-day change 1-year change 3-year change Capi.($)
-79.67%-.--% - - 834K
+1.43%-1.18%-5.07%-5.39% 238B
-2.58%-7.20%+11.96% - 45.7B
-2.96%-14.63%+81.15% - 10.95B
+0.61%-8.52%+41.59%-42.15% 8.82B
+0.56%-4.85%+20.72%+7.18% 6.57B
+2.10%+5.35%-17.99%-19.93% 6.47B
+2.35%-0.93%+1.94%-17.08% 3.74B
+0.51%+2.75%-22.93%-44.31% 3.68B
+0.36%-2.03%-4.73%-41.30% 2.86B
Average -7.73%-3.30%+11.85%-23.28% 36.26B
Weighted average by Cap. +0.69%-2.55%+1.62%-7.70%

Financials

2024 2025
Net sales 113K 81.75K 70.46K 66.21K 60.5K 7.73M 114K 783K 303K 3.96M 307K 301K 12.78M 67.89K 49.02K 42.25K 39.7K 36.28K 4.63M 68.17K 470K 182K 2.38M 184K 180K 7.66M
Net income -456K -329K -284K -267K -244K -31.14M -458K -3.16M -1.22M -15.97M -1.24M -1.21M -51.5M -631K -456K -393K -369K -337K -43.09M -634K -4.37M -1.69M -22.1M -1.71M -1.68M -71.26M
Net Debt 265K 191K 165K 155K 142K 18.1M 266K 1.83M 710K 9.28M 720K 704K 29.93M 211K 152K 131K 123K 113K 14.39M 212K 1.46M 564K 7.38M 572K 559K 23.79M
Logo Ovation Science Inc.
Ovation Science Inc. is a Canada-based drug development company. The Company develops topical and transdermal cannabidiol (CBD)/ tetrahydrocannabinol (THC) and other cannabinoid products which are out-licensed and also distributed under its own brands; ARLO CBD Beauty and InVibe MD (wellness line); all powered by its patented Invisicare skin delivery technology. The Company manufactures, distributes, sells, markets, sub-licenses and promotes products formulated with Invisicare, containing cannabinoids, hemp seed oil or synthetic derivatives of cannabis. The Company has developed topical and transdermal creams and lotions made with CBD, THC and combinations thereof plus hemp seed oil. Invisicare is a patented polymer-based technology for topical and transdermal skincare products. ARLO CBD Beauty offers science-based skincare solutions. Invibe MD offers a health and wellness product line infused with hemp-derived CBD and developed using Invisicare drug delivery technology.
Employees
-